A Salmonella enterica serovar Typhi gene that is selectively up-regulated upon bacterial invasion of eukaryotic cells was characterized. The open reading frame encodes a 298-amino-acid hydrophobic polypeptide (30.8 kDa), which is predicted to be an integral membrane protein with nine membrane-spanning domains. The protein is closely related (87 to 94% reliability) to different transport and permease systems. Gene expression under laboratory conditions was relatively weak; however, sevenfold induction was observed in a high-osmolarity medium (300 mM NaCl). The growth pattern in a laboratory medium of a serovar Typhi strain Ty2 derivative containing a 735-bp in-frame deletion in this gene, named gaiA (for gene activated intracellularly), was not affected. In contrast, the mutant was partially impaired in intracellular survival in murine peritoneal macrophages, as well as in human monocyte-derived macrophages. However, in the case of human macrophages, this survival defect was modest and evident only at late infection times (24 h). Despite the distinct intracellular survival kinetics displayed in macrophages of different species, the gaiA null mutant was significantly affected in its potential to trigger apoptosis in both murine and human macrophages. Provision of the gaiA gene in trans resulted in complementation of these phenotypes. Interestingly, the absence of a functional gaiA gene caused a marked attenuation in the mouse mucin model, as shown by the increase (3 orders of magnitude) in the 50% lethal dose of the mutant strain over that of the parental strain Ty2 (P < 0.05). Altogether, these data indicate that the product encoded by the gaiA gene is required for triggering apoptosis and bacterial survival within murine macrophages, which is consistent with the in vivo results obtained in the mouse mucin model. However, gaiA was not required for initial intracellular survival in human cells, indicating that its role in the natural host might be more complex than is suggested by the studies performed in the murine system.
Infections caused by Salmonella enterica serovars constitute a major public health problem worldwide (1, 20) . These pathogens can affect both humans and animals, causing food-borne diseases ranging from mild gastroenteritis to life-threatening systemic infections, such as those caused by S. enterica serotype Typhi in humans (19, 20, 41) . The clinical management of patients infected with S. enterica serovars is rendered difficult due to the emergence of multidrug-resistant strains (47) .
S. enterica serovar Typhi has a particularly complex infection cycle, in which the microorganism transits through different niches (41, 55) . It has been demonstrated that during infection, the expression of bacterial products is tightly regulated according to environmental signals (10) . This allows the pathogen to optimize the expression of the virulence factors required in each phase, avoiding the additional energetic cost associated with the production of unnecessary products. Better understanding of the molecular basis of Salmonella infections has led to identification of bacterial products which are essential for pathogenicity, such as virulence factors, regulatory proteins, and secretion systems (15, 19) . The corresponding genes constitute potential targets for the development of attenuated strains, which can be used either as live vaccines against salmonellosis or as carriers for heterologous antigens (7, 32) .
Serovar Typhi promoters that are activated mainly upon bacterial entry into eukaryotic cells have been identified previously (58) . It is likely that the genes controlled by these promoters are involved in the infection process to some extent. Precedents exist in S. enterica serovar Typhimurium demonstrating that genes induced inside cultured macrophages or epithelial cells are essential for virulence. This is the case for the spv operon and the mig-14 gene (13, 61) . In this work we describe the characterization of a novel serovar Typhi gene driven by one of those promoters. The results obtained suggest that this gene is involved in the interactions between bacteria and phagocytic cells.
MATERIALS AND METHODS
Bacterial strains, plasmids, and media. The strains and plasmids used in this study are described in Table 1 . Bacteria were grown in Luria-Bertani (LB) broth (48) or LB agar plates. Plasmids were maintained in the Escherichia coli strain XL1-Blue, and the INV␣FЈ strain was used as a recipient for cloning fragments amplified by PCR and cloned into the pCR2.1 vector. Media were supplemented with chloramphenicol (50 g ml Ϫ1 ), ampicillin (200 g ml Ϫ1 ), nalidixic acid (20 g ml Ϫ1 ), or streptomycin (50 g ml Ϫ1 ) when required. DNA manipulations. Plasmid DNA isolation, restriction endonuclease digestion, ligation, transformation, agarose gel electrophoresis, and other standard DNA techniques were carried out as described by Sambrook et al. (48) . Oligo-nucleotides (Table 2) were synthesized by GIBCO. Colony PCR, extraction of PCR products, and cloning experiments were performed according to standard protocols (48) . Inverse PCR was carried out as described by Ochman et al. (40) . DNA sequencing was performed by using a Taq dye-deoxy terminator cycle sequencing kit and a model 373A automatic DNA sequencer (Perkin-Elmer Applied Biosystems, Foster City, Calif.), according to the manufacturer's instructions. Restriction and modification enzymes were purchased from New England Biolabs (Frankfurt, Germany). Electroporation was carried out with a gene pulser (Bio-Rad Laboratories, Richmond, Calif.) as described by O'Callaghan and Charbit (39) . Searches in databases for nucleotide and amino acid sequence homologies were performed by using the BLASTP (2), BLASTP plus BEAUTY (2, 66), FASTA3 (42) , and PSORT (36) algorithms.
Construction of a nonpolar mutation. Overlap extension PCR (27) was used to generate an in-frame deletion in the gaiA gene. Two PCR fragments were obtained by using the primer pairs 5102XBA and 3⌬172 (447 bp) and 5⌬1823 and SEQAPOR2 (510 bp). The resulting products contain the first 87 bp and the last 72 bp of the gaiA open reading frame (ORF), respectively. An 18-bp overlap in their sequences allowed the amplification of a 934-bp fragment during a second PCR using the primer pair 5102XBA and SEQAPOR2. The resulting product, which encompasses a gaiA gene containing an internal 735-bp deletion, was digested with XbaI and cloned into XbaI-digested pKNG101 (30), generating pHOB35. This plasmid was transformed into strain SM10 (pir) and then transferred by conjugation (25) into the recipient S. enterica serovar Typhi strain Ty2 (Nal r ). Cointegration and excision of the suicide vector were performed as previously described (30) . The in-frame deletion contained in the serovar Typhi gaiA mutant resulting from the allelic exchange was confirmed by PCR analysis using primers homologous to regions encompassed in the deleted fragments or to adjacent external sequences (data not shown). Primers 5102XBA and SEQA-POR2 were used to amplify the full-length gaiA gene and 360 bp of the region located upstream of the start codon, which was subsequently cloned into the low-copy-number vector pVDL8 (60), generating pHOB38, which was used for complementation studies. Construction of a gaiA-lacZ fusion. For construction of a gaiAЈ-ЈlacZ fusion, a 431-bp EcoRI/BamHI-fragment amplified by PCR using primers 5102ECO and 3LACZBAM, which contains 375 bp of the upstream sequence of gaiA and 56 bp of the gaiA gene, was cloned into pUJ9TT (29) , generating pHOB700. ␤-Galactosidase activity was quantified by the method of Miller (33) .
Tissue culture methods, invasion tests, and in vivo studies. S. enterica serovar Typhi strains were tested for the ability to survive in Henle 407 cells (ATCC CCL-6) and the macrophage-like cell line J774A.1 (ATCC TIB 67). Primary macrophages were either obtained from the peritoneal cavities of BALB/c mice or derived from human peripheral blood mononuclear cells obtained from healthy volunteers as previously described (43) . Henle 407 cells were maintained in Dulbecco's modified Eagle medium (DMEM) supplemented with 25 mM HEPES, 10% (vol/vol) fetal calf serum (FCS), and 5 mM glutamine (GIBCO). Macrophages were maintained in DMEM (Sigma Chemie GmbH, Deisenhofen, Germany) supplemented with 4.5 g of glucose/liter, 10% FCS, 5 mM glutamine, and 1.5 g of NaHCO 3 /liter in an atmosphere containing 5% CO 2 at 37°C. Cells seeded at a concentration of approximately 5 ϫ 10 4 per well in 24-well tissue culture plates (Inter Med NUNC, Roskilde, Denmark) were infected with bacteria grown overnight in static LB broth cultures supplemented with 17.53 g of NaCl/liter during 90 min (Henle cells), 60 min (human macrophages), or 30 min (murine macrophages and J774A.1 cells), as previously described (22, 29) . The number of apoptotic cells was determined by using an in situ cell death detection kit with fluorescein (Boehringer Mannheim GmbH) according to the manufacturer's instructions. The mouse mucin model described by Powell et al. (44) was used for determination of the 50% lethal dose (LD 50 ) (45) .
Statistical analysis. The statistical significance of the results obtained was evaluated by the chi-square test.
Nucleotide sequence accession numbers. The nucleotide sequences reported here have been deposited in the EMBL database under accession number AJ006101. 
RESULTS AND DISCUSSION
Identification of an S. enterica serovar Typhi gene that is activated upon infection of eukaryotic cells. A previous study allowed the identification of serovar Typhi promoters that were activated upon invasion of eukaryotic cells (58) . By use of the gene encoding chloramphenicol acetyltransferase (cat) as a reporter, it was estimated that the activity of the promoter contained in vector pLS102 was increased 93-fold when bacteria entered eukaryotic cells (58) . This vector carries a 548-bp fragment of serovar Typhi DNA containing a promoter motif reminiscent of 54 -dependent promoters, a Shine-Dalgarno sequence, and the start of an ORF at position 372 (58) .
Total DNA from the serovar Typhi strain Ty2 was digested with different restriction endonucleases recognizing sequences present in the insert from pLS102 and was subsequently analyzed by Southern blotting using the digoxigenin-labeled insert from pLS102 as a probe. A 1,600-bp fragment that reacted specifically with the probe was identified by using ApoI. To identify the sequences located downstream of the truncated ORF present in pLS102, this 1,600-bp fragment was amplified by inverse PCR using primers REVSD and 5102B, with ApoIdigested DNA as a template. Sequence analysis of the resulting fragment allowed us to design primer SEQAPOR2, corresponding to the 3Ј end, which was used together with primer 5102XBA to PCR amplify the whole ORF by using chromosomal DNA from the serovar Typhi strain Ty2 as a template.
The gene present in the cloned fragment, which was named gaiA (for gene activated intracellularly), encodes a 298-aminoacid hydrophobic polypeptide with a predicted molecular mass of 30.8 kDa and a pI of 10.02. A potential leader peptide with a cleavage site at positions 18 and 19 (ACL-GL) was detected by using the SignalP algorithm (37) . Use of the TopPred II algorithm (9) suggested with 95% reliability that the GaiA protein is an integral membrane protein with nine membranespanning domains (Fig. 1) . Interestingly, nine predicted Nmyristoylation sites were also detected; one of them was located at the predicted leader peptide cleavage site (GLALGG; positions 19 to 24). In gram-negative bacteria the myristoylation of lipid A is essential for its proinflammatory properties, which are essential for a virulent phenotype (23, 56, 57) . However, the covalent attachment of a myristoyl group to an NH 2 -terminal glycine residue seems to occur exclusively in eukaryotic cells (3, 53) . Nevertheless, recent studies have proved that proteins exported from prokaryotic cells can also be N myristoylated by the machinery of target cells (38, 54) .
Searches for homologies in databases showed that the product encoded by the gaiA gene exhibits 88% identity (293-amino-acid overlap) with the putative transport protein coded by the f451 ORF from E. coli (YICM_ECOLI; P31438) and 87% identity with the corresponding allelic variant of the E. coli strain EDL933 (AAG588858). The E. coli yicM gene is located in the intergenic fragment between the uhpT and nlpA genes (5). uhpT is involved in the uptake of phosphorylated sugars (14, 63, 64) , whereas nlpA is a lipoprotein attached to the cytoplasmic membrane (68) . The location of the gaiA gene was examined in the genomes of S. enterica serovars Typhi and Typhimurium by using the "Enteric" server (http://galapagos.cse.psu.edu/enterix/enteric/enteric.html). This analysis revealed that, unlike its E. coli homologue, gaiA/yicM is flanked by several ORFs of unknown function that are absent in the E. coli genome (10 and 9 ORFs in the upstream and downstream regions, respectively). Moreover, 12 ORFs upstream of gaiA/ yicM is the mgtC gene, which has been shown to be the first gene of a 17-kb region encompassing Salmonella pathogenicity island 3 and required for intramacrophage survival (4). This evidence suggests that gaiA/yicM has been conserved between the two genera but that in the case of Salmonella, extensive chromosomal rearrangement of the genome has occurred in its flanking regions, including insertion of a pathogenicity island.
The product encoded by the gaiA gene was also analyzed by using the Propsearch algorithm (28), which detects functional or structural homologues belonging to putative protein families by using 144 properties (e.g., amino acid composition, molecular weight, content of bulky or small residues, average hydrophobicity, and charge). The Euclidian distance between the product encoded by gaiA and other database sequences suggested that this protein is related with a 87 to 94% reliability to different transport systems (e.g., sugars, cytosine, ABC transporters, arsenic pumps, branched amino acids, Na ϩ /H ϩ antiporter). This suggests that the product encoded by this gene may be involved in the transport of substrates required for bacterial metabolism.
Transcriptional regulation of the gaiA gene. Previous results demonstrated that the promoter driving the expression of the gaiA gene is activated intracellularly (58) . To gain further knowledge about the potential environmental signals mediating gene activation, a translational fusion was generated between gaiA and the gene coding for ␤-galactosidase (lacZ), which was used as a reporter. A DNA fragment spanning nucleotides Ϫ375 to ϩ56 (with respect to the gaiA ATG start codon) was fused to the lacZ gene present in pUJ9TT (see Materials and Methods), generating plasmid pHOB700. This fragment includes the promoter and upstream regions, containing potential binding sites for regulatory factors, and maintains intact the translational initiation region in order to avoid potential artifacts deriving from affected translational initiation (50). The pHOB700 plasmid was highly unstable in wild-type Salmonella strains, even when passed through an intermediate rec-negative mod ϩ serovar Typhimurium strain, suggesting that this may be partly due to recombination events. Thus, transcriptional activation studies were performed by using Salmonella strain MT189 (recA1), in which the construct was stable, as a recipient.
In the initial studies the influence of the growth phase on the expression of the reporter gene was analyzed ( Fig. 2A) , since this factor seems to play a key role in Salmonella invasion (11, 12, 31, 59) . A minor increase in the expression of the reporter was observed at the early-exponential phase, followed by a second increment at the late-exponential and early-stationary phases ( Fig. 2A) . In contrast, when the effect of changes in osmolarity was analyzed, a clear increment of about sevenfold in the expression of lacZ was observed at 0.3 M NaCl (Fig. 2B) . Interestingly, bacterial growth at lower and higher osmolarities resulted in reduced expression. This is in agreement with what was previously observed for the adhesive and invasive phenotypes (optimal at 0.3 M NaCl) and the expression of different virulence factors and type III secretion systems (15, 16, 59) . Since the availability of Mg 2ϩ has been also reported to affect Salmonella virulence, via the response regulator PhoP/PhoQ GaiA is involved in the interactions between serovar Typhi and macrophages. To assess whether the product encoded by gaiA is involved in the pathogenesis process, a serovar Typhi Ty2 mutant containing a 735-bp in-frame deletion in this gene was generated as described in Materials and Methods. The serovar Typhi ⌬gaiA strain did not differ from the parental strain in terms of growth pattern in LB medium, morphology (by light microscopy), or expression of the Vi antigen (data not shown).
The capacity of the null mutant to infect and survive within epithelial cells was then evaluated. No statistically significant differences were observed in the number of viable intracellular bacteria recovered following 4, 6, 8, and 24 h of infection of Henle 407 epithelial cells (data not shown). Then we analyzed whether the ⌬gaiA mutant was able to survive within professional phagocytes. Upon infection of mouse peritoneal macrophages, the serovar Typhi ⌬gaiA strain displayed a 46 to 77% reduction (P Յ 0.05) in the number of viable intracellular bacteria from that for the wild type at 1.5 and 3 h postinfection, respectively (Fig. 3A) . To confirm the role played by the product encoded by the ⌬gaiA gene in the phenotype observed, a plasmid containing a PCR fragment encompassing the fulllength gaiA gene and 360 bp of the regions located upstream of the ATG start codon (pHOB38) was introduced into the serovar Typhi ⌬gaiA mutant. The provision of gaiA in trans resulted in full complementation of the mutant phenotype, re- on August 15, 2017 by guest http://iai.asm.org/ storing intracellular survival levels to those of the wild-type parental strain (Fig. 3A) . It is unlikely that the differences observed were due to impaired infectivity, since the number of viable bacteria recovered per well after 30 min of infection was in the range of 1 ϫ 10 5 to 2 ϫ 10 5 for all strains tested. It has been demonstrated that S. enterica serovar Typhimurium is able to trigger apoptosis of infected macrophages (6, 8, 26, 35, 49, 69) . This process seems to play a key role also in elicitation of immune responses to Salmonella (67, 69) . Since the intracellular survival of the mutant strain was reduced only in macrophages, not within epithelial cells, we decided to assess whether the capacity of the serovar Typhi ⌬gaiA mutant to stimulate programmed cell death was also affected. The murine macrophage-like cell line J774A.1 was infected with serovar Typhi Ty2 or its ⌬gaiA derivative, and the number of apoptotic cells was determined after 8 h by a terminal deoxynucleotidyltransferase-mediated dUTP-fluorescein nick end labeling (TUNEL) assay (Fig. 4) . Approximately 41% of cells infected with serotype Typhi Ty2 underwent apoptosis after 8 h of infection. In contrast, only 4% of the cells infected with the ⌬gaiA mutant exhibited signs of apoptosis. The capacity to promote apoptosis was restored in the ⌬gaiA mutant complemented with pHOB38.
Infected macrophages play a key role in Salmonella infections (21, 41) . However, intracellular survival is host dependent. While serovar Typhimurium can survive within both mouse and human macrophages, serovar Typhi survives at reasonable rates only within human macrophages (51, 62) . Serovar Typhi also exhibits a particular survival kinetics in human macrophages, which is characterized by an initial phase of bacterial death followed by a second phase of persistent survival. Furthermore, serovar Typhimurium usually causes more apoptosis than serovar Typhi (51) . Therefore, it has been proposed that serovar Typhi can survive chronically within human macrophages by causing little damage, thereby favoring systemic dissemination.
Humans are the natural hosts for serovar Typhi. Therefore, to further characterize the role played by the product encoded by the gaiA gene, monocyte-derived human macrophages were infected. Surprisingly, significantly higher numbers of viable bacteria were recovered from cells infected with the Ty2 ⌬gaiA mutant than from those infected with the parental strain (P Յ 0.05) after 3 h of infection (Fig. 3B) . This consistent increment in survival was abolished by providing the gaiA gene in trans (Fig. 3B) . However, the initial survival pattern was reverted 24 h after infection, with the ⌬gaiA mutant exhibiting a slightly lower viability than the wild-type strain. Provision of the gaiA gene in trans resulted in full complementation of the mutant phenotype (Fig. 3B) . To better characterize the dynamics of the intracellular survival process for each strain tested, survival indexes (the number of viable bacteria after 24 h divided by the number of viable bacteria after 3 h) were calculated. The survival index of the wild-type strain was 4.2, showing that there was a significant increment in the number of viable bacteria after 24 h. In contrast, the survival index of the ⌬gaiA mutant was 0.48, demonstrating that there was a marked reduction in the number of viable bacteria during the course of infection. When the gaiA gene was provided in trans, the phenotype of the deletion mutant reverted, and the survival index was even higher than that of the wild-type strain (6.6).
Thus, it seems that during short-term infection of human macrophages the gaiA gene is not required for intracellular survival, and indeed, its loss causes an apparent abolishment of the initial phase of bacterial death. To evaluate whether this phenotype could be related to differences in the capacity to trigger macrophage apoptosis, we monitored the percentages of apoptotic cells in human macrophages infected with the wild-type and mutant strains. The results obtained (Fig. 4) demonstrated that the ability of the ⌬gaiA mutant to trigger apoptosis was significantly reduced from that of the wild-type strain (P Յ 0.05). When the gaiA gene was provided in trans, full complementation of the mutant phenotype was observed (Fig. 4) . Thus, it seems that the difference in survival kinetics displayed by the ⌬gaiA mutant in murine and human macrophages is not related to an impaired capacity to trigger apoptosis. Interestingly, it has been demonstrated that spvA, another Salmonella gene which is induced in intracellular bacteria, follows a differential kinetics of induction in both macrophages and epithelial cells, displaying maximal induction (Ն100-fold) 6 to 8 h postinfection (65) . Considering our results, it is tempting to postulate a potential role for gaiA in bacterial survival within human macrophages during late infection.
S. enterica serovar Typhi is avirulent for mice. This seems to reflect its inability to grow in murine macrophages. However, the use of iron-enriched mucin results in iron overloading, which increases bacterial growth within phagocytic cells (52) .   FIG. 4 . Salmonella-mediated apoptosis of infected cells. The capacities of the serovar Typhi strain Ty2, its ⌬gaiA derivative, and the ⌬gaiA mutant complemented with pHOB38 to trigger apoptosis in J774A.1 cells and monocyte-derived human macrophages were evaluated and compared with that of the positive-control serovar Typhimurium strain LT2. Results are expressed as percent apoptotic cells. Asterisks indicate that the differences from results for the parental strain S. enterica serovar Typhi Ty2 were considered significant (P Յ 0.05).
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In an attempt to further characterize the role of gaiA, the in vivo virulence of the serovar Typhi ⌬gaiA mutant was evaluated by using the mouse mucin model. Under these conditions, the LD 50 calculated for the ⌬gaiA mutant (2.1 ϫ 10 7 CFU) was approximately 3 orders of magnitude higher than that for the parental strain Ty2 (4.78 ϫ 10 4 CFU). This result suggests that the presence of a functional gaiA gene is required in vivo for expression of a fully virulent phenotype in the murine mucin model, which agrees with the observed defects of the ⌬gaiA mutant in triggering apoptosis and in surviving within murine macrophages. However, we should be cautious when evaluating these data, since mice are not the natural hosts for serovar Typhi.
Salmonella genes which are selectively activated upon infection of eukaryotic cells are likely to be either housekeeping genes or genes encoding novel virulence factors. Preliminary studies suggest that GaiA may be involved in the transport or utilization of carbon sources (data not shown). The cytoplasm of infected cells might be a nonpermissive environment for intracellular pathogens, unless they are able to express special metabolic genes. Although serovar Typhi is a pathogen that resides in membrane-bound compartments of the host cell, its proliferation within these compartments must rely on the acquisition of nutrients that are probably present in the cytoplasm. The potential involvement of GaiA in the transport or utilization of carbohydrates, as well as in bacterial interactions with phagocytes, suggests that it might play an essential role in bacterial nutrition or as a factor coupled to the expression of genes involved in the pathogenesis process. A connection between a nutrition-related function and the induction of virulence genes has been shown for Listeria monocytogenes (18, 46) , a pathogen that proliferates in the host cell cytoplasm.
However, with regard to the real role played by the gaiA product, our studies do not reveal what the exact biological function of the GaiA protein during the infection process could be. In fact, direct proof of the involvement of GaiA in pathogenesis in its natural host is still lacking. Serovar Typhi is extremely sensitive to murine macrophages, and the mutant analyzed in this study showed only a slight survival defect at late infection times in monocyte-derived human macrophages. Additional work focused on analysis of the interaction of the serovar Typhi gaiA mutant with other human immune-system cells, such as dendritic cells, or, alternatively, analysis of the capacity of the corresponding serovar Typhimurium mutant to trigger disease in mice might provide further insights into the overall function of this gene during natural infections.
